MicroRNA‑24 attenuates diabetic vascular remodeling by suppressing the NLRP3/caspase‑1/IL‑1β signaling pathway

Zhixing Fan1, Jian Yang2, Chaojun Yang3

  • 1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.

Insights

MicroRNA-24 (miR-24) overexpression suppresses inflammation and vascular remodeling in diabetic rats. This study shows miR-24 attenuates diabetic cardiovascular complications by inhibiting the NLRP3 inflammasome pathway.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Endocrinology

Background:

  • Diabetic cardiovascular complications are linked to vascular remodeling.
  • MicroRNA-24 (miR-24) is implicated in diabetic vascular remodeling, but mechanisms are unclear.
  • The NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome pathway is a potential target.

Purpose of the Study:

  • To investigate if miR-24 overexpression suppresses the NLRP3 inflammasome pathway.
  • To determine if miR-24 attenuates diabetic vascular remodeling in a rat model.

Main Methods:

  • Adenovirus-mediated miR-24 overexpression in diabetic rat carotid arteries.
  • Reverse transcription-quantitative PCR and western blotting for gene and protein expression.
  • Histological analyses (H&E, immunohistochemistry, Masson's trichrome staining).

Main Results:

  • miR-24 upregulation reduced neointimal hyperplasia and enhanced reendothelialization.
  • miR-24 suppressed NLRP3, caspase-1, IL-1β, IL-18, TNF-α, PCNA, and CD45 expression.
  • miR-24 increased CD31, smooth muscle α-actin, and SM-myosin heavy chain expression.

Conclusions:

  • miR-24 overexpression attenuates vascular remodeling in diabetic rats.
  • The mechanism involves the suppression of the NLRP3/caspase-1/IL-1β signaling pathway.
  • miR-24 is a potential therapeutic target for diabetic vascular complications.